x
SIGN UP
About Us
Back
Overview
Leadership Team
Board of Directors
Scientific Advisory Board
Partners
Careers
Science & Technology
Back
Protein Misfolding
SEE-Tx™ Platform
STARs
Publications
Posters
Pipeline
Back
Investors & Media
Back
Overview
News and Events
Stock Information
SEC Filings
Corporate Governance
Investor Resources
Analyst Coverage
Contact Us
Back
Perspectives
SearchIcon
Newsroom
Search
Lysosomal storage disorder biotech Gain Therapeutics prices IPO at $11 midpoint
Lysosomal storage disorder biotech Gain Therapeutics prices IPO at $11 midpoint
